INTRODUCTION
============

Cats are susceptible to various gastrointestinal parasites, including Nematoda (*Toxocara* spp., *Aelurostrongylus abstrusus, Strongyloides* spp., and *Ancylostoma* spp.), Trematoda (*Clonorchis sinensis* and *Paragonimus* spp.), Cestoda (*Taenia taeniaeformis, Spirometra mansoni, Diphyllobothrium* spp., and *Echinococcus multilocularis*), Coccidia (*Cystoisospora* spp., *Toxoplasma gondii, Cryptosporidium* spp., and *Sarcocystis* spp.), and Trepomonadea (*Giardia duodenalis*). Some of these can infect humans as well as animals \[[@b1-kjp-57-3-243]--[@b5-kjp-57-3-243]\]. Of these parasites, infections by helminths are the most common in cats and dogs, despite the availability of numerous effective anthelmintic products \[[@b6-kjp-57-3-243]\]. However, less data exist for parasitism on cats than for dogs \[[@b7-kjp-57-3-243]\]. In the Republic of Korea, several studies of gastrointestinal parasites in cats are available, however, the studies were done in restricted regions, several decades ago \[[@b2-kjp-57-3-243],[@b8-kjp-57-3-243],[@b9-kjp-57-3-243]\]. Up-to-date information on gastrointestinal parasite infection in cats is scarce.

Concerning administration routes, topical treatment with anthelmintics is preferred because it is more convenient and less stressful than oral administration for both cats and their owners \[[@b10-kjp-57-3-243]\]. Emodepside 2.1% (w/v) plus praziquantel 8.6% (w/v) (Profender® spot-on, Bayer, Kiel, Germany) is a topically applied anthelmintic drug with broad-spectrum activity. The product is intended for treatment of gastrointestinal parasites in cats, including nematodes (*Toxocara cati, Toxascaris leonina*, and *Ancylostoma tubaeforme*) and cestodes (*Dipylidium caninum, T. taeniaeformis*, and *E. multilocularis*). Previous studies showed that the product has high efficacy (\>98.5%) against susceptible gastrointestinal parasites \[[@b4-kjp-57-3-243],[@b6-kjp-57-3-243]\]. Emodepside belongs to a new class of anthelmintic compounds called cyclooctadepsipeptides. It is a derivative of PF1022A, and shows various anthelmintic activities in animals \[[@b11-kjp-57-3-243]\]. Praziquantel is a pyrazinoisoquinoline derivative that has shown effectiveness against cestodes in large and small animals \[[@b10-kjp-57-3-243],[@b12-kjp-57-3-243]\].

The purpose of the present study was to investigate the prevalence of gastrointestinal parasites in cats from Daegu, Republic of Korea, based on microscopic examination. In addition, this study evaluated the efficacy and safety of topical emodepside/praziquantel in naturally parasite-infected cats.

MATERIALS AND METHODS
=====================

Sample collection
-----------------

Before the study was conducted, written consent was obtained from the owners. Daegu, Republic of Korea, is located at longitude 128°36′ East and latitude 35°52′ North, with a mean annual temperature of 14.1°C and a mean annual precipitation of 1,064.4 mm \[[@b13-kjp-57-3-243]\]. A total of 407 cat fecal samples were collected from a local veterinary clinic and animal shelter in Daegu, Republic of Korea, from June 2012 to August 2015. The average weight of the cats was 2.2 kg, with a standard deviation of 1.5 kg. The cats selected were classified according to sex (male or female), age (young, \<1-year-old; adult, ≥1-year-old), and type of cat (companion or stray cat). The fecal samples were collected from the cages where the cats were kept. The samples were fresh, not dried. After collection, the fecal samples were transported to the College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea, and were stored at 4°C until examined microscopically.

Identification of gastrointestinal parasite eggs
------------------------------------------------

Identification of gastrointestinal parasite eggs from cat fecal samples was based on morphology, using a flotation method with a saturated sodium chloride solution \[[@b3-kjp-57-3-243]\]. The severity of infection was judged by the number of parasite eggs, using a modified McMaster method \[[@b3-kjp-57-3-243]\]. Eggs per gram of feces (EPG) were calculated and then categorized into three groups: mild, EPG\<1,000; moderate, 1,000≤EPG\<10,000; severe, EPG≥10,000.

Treatment of anthelmintics
--------------------------

After the fecal examination, cats that were positive for gastrointestinal parasites (n=162) received a single topical application of emodepside/praziquantel (Profender® spot-on), according to the manufacturers' instructions. *Cystoisospora felis*-infected cats were excluded, because the drug is not considered effective for this species. The treatment was applied to the skin of the cat's neck at the base of the skull while hairs were put aside without shaving.

Evaluation of efficacy and safety
---------------------------------

The efficacy of the emodepside/praziquantel treatment was determined through microscopic examination of gastrointestinal parasite eggs from cat fecal samples, as previously described, five days after treatment. Safety was determined by identification of any behavior abnormalities or clinical symptoms by the veterinarians or owners.

Statistical analysis
--------------------

To evaluate statistically significant differences in prevalence as a function of sex, age, or companion/stray status, the Chi-square test was applied using SPSS V.21.0 (IBM Corporation, Armonk, New York, USA). A *P*-value less than 0.05 was regarded as statistically significant. Also, 95% confidence intervals were calculated.

RESULTS
=======

Prevalence of gastrointestinal parasites
----------------------------------------

Of the 407 cat fecal samples tested, 162 (39.8%) were infected by at least one of the gastrointestinal parasites ([Table 1](#t1-kjp-57-3-243){ref-type="table"}). Concerning sex, 76 of 195 male cats (39.0%) and 86 of 212 female cats (40.6%) showed positive fecal samples; the difference in prevalence was not statistically significant (*P*=0.743). Concerning age, 79 of 218 young cats (36.2%) and 83 of 189 old cats (43.9%) showed positive samples; the difference was not statistically significant (*P*=0.115). Concerning the type of cat, stray cats showed a higher prevalence (97 of 183, 39.8%) than cats with owners (65 of 224, 29.0%); this difference was statistically significant (*P*\<0.001).

Based on morphology, *T. cati, T. leonina, T. taeniaeformis*, and *C. felis* were identified in 102 (63.0%), 51 (31.5%), 6 (3.7%), and 3 (1.9%) cat fecal samples, respectively ([Fig. 1](#f1-kjp-57-3-243){ref-type="fig"}; [Tables 2](#t2-kjp-57-3-243){ref-type="table"}, [3](#t3-kjp-57-3-243){ref-type="table"}). When the data were analyzed according to the parasite species, there were no statistically significant differences as a function of sex or age (*P*\>0.05); however, *T. cati* and *T. leonina* both showed significantly higher prevalence in stray cats than in companion cats, with *P*-values of 0.003 and 0.001, respectively. Most of the cats were mildly infected (140/162; 86.4%); no severe infections were observed ([Table 3](#t3-kjp-57-3-243){ref-type="table"}). No concurrent infections with two or more parasites were recorded.

Efficacy and safety of the treatment
------------------------------------

At the day 5 after treatment, all the fecal samples were reexamined but no parasite eggs were detected under microscopy. In addition, there were no reports of adverse drug effects, including abnormal behavior or clinical symptoms, from the veterinarians or owners, following administration of the topical treatment.

DISCUSSION
==========

Feline gastrointestinal parasites have been reported worldwide, but with greatly different prevalence, for example, 39.6% (71/179) in the USA \[[@b14-kjp-57-3-243]\], 58.3% (271/465) in Argentina \[[@b15-kjp-57-3-243]\], 34.3% (142/414) in Romania \[[@b1-kjp-57-3-243]\], 22.8% (1,952/8,560) in Germany \[[@b16-kjp-57-3-243]\], 88.5% (46/52) in Iran \[[@b17-kjp-57-3-243]\], 35.1% (533/1,519) in Europe \[[@b7-kjp-57-3-243]\], and 86.3% (44/51) in Iran \[[@b5-kjp-57-3-243]\]. The variability in prevalence seen in these studies might be attributed to differences in sampling region, season, habitat, and the number of samples. In the Republic of Korea, a few decades ago, there were several studies regarding gastrointestinal parasites in cats. In most cases, the studies were restricted to specific regions, and the prevalence varied accordingly, from 75.6% to 85.6% \[[@b2-kjp-57-3-243],[@b8-kjp-57-3-243],[@b9-kjp-57-3-243]\].

The overall prevalence of gastrointestinal parasite infections in cats in this study was 39.8% (162/407). The results differed according to age, with adults showing higher prevalence than young cats, but this was not statistically significant (*P*=0.115). There have been debates regarding the relationship between gastrointestinal infection and age \[[@b5-kjp-57-3-243],[@b7-kjp-57-3-243],[@b16-kjp-57-3-243],[@b17-kjp-57-3-243]\], however, each study was based on a different age classification, study region, and sample size; therefore, better-controlled studies are required. Regardless of the debate, the prevalence of gastrointestinal parasites in both young and adult cats indicates a susceptibility to infection in all life stages \[[@b5-kjp-57-3-243]\]. There were no significant differences between male and female cats in prevalence. Many previous studies have reported similar observations for different regions \[[@b1-kjp-57-3-243],[@b5-kjp-57-3-243],[@b17-kjp-57-3-243],[@b18-kjp-57-3-243]\]. Stray cats showed significantly higher prevalence than companion cats, for infections in general as well as for the specific parasite species *T. cati* and *T. leonina*. Previous studies targeted at stray cats showed a very high prevalence (\>85%) of gastrointestinal parasites \[[@b2-kjp-57-3-243],[@b5-kjp-57-3-243],[@b17-kjp-57-3-243]--[@b19-kjp-57-3-243]\], compared to house cats (\<35%) \[[@b1-kjp-57-3-243],[@b7-kjp-57-3-243],[@b16-kjp-57-3-243]\]. The prevalence in stray cats in the present study are not as high as in the previous studies; however, it was significantly higher than in the companion cats. Because the stray cats roamed freely before they were taken to the animal shelter, they had many more chances to be exposed to parasites. It is worth noting that the companion cats, although generally reared inside houses, also showed a high enough prevalence to require regular anthelmintic treatment.

The following parasites were detected in this study: *T. cati* (63.0%), *T. leonina* (31.5%), *T. taeniaformis* (3.7%), and *C. felis* (1.9%). The study found that *T. cati* was the most prevalent parasite, which is consistent with reports of 53.3% in England \[[@b20-kjp-57-3-243]\], 55.2% in Spain \[[@b19-kjp-57-3-243]\], 61.2% in Argentina \[[@b15-kjp-57-3-243]\], 20.3% in Romania \[[@b1-kjp-57-3-243]\], and 28.8% in Iran \[[@b17-kjp-57-3-243]\]. In addition, previous studies in different regions of the Republic of Korea also showed *T. cati* forming the largest fraction of gastrointestinal parasite cases \[[@b2-kjp-57-3-243],[@b8-kjp-57-3-243],[@b9-kjp-57-3-243]\]. Two factors may explain the high prevalence of *T. cati* in cats. First, cats often roam freely and discharge eggs of the parasite in the environment, which then contaminate soils \[[@b21-kjp-57-3-243]\]. Second, the parasite can be transmitted by breastfeeding, so *T. cati*-infected maternal cats can pass the infection to their non-infected kittens \[[@b22-kjp-57-3-243]\]. In contrast to our results showing *T. leonina* as the second most prevalent helminth in cats, at 30.6%, previous studies reported variable prevalences according to countries (0.1--12.9%) \[[@b16-kjp-57-3-243],[@b18-kjp-57-3-243],[@b23-kjp-57-3-243]\]. To evaluate accurate prevalence and distribution of *T. leonina*, more samples from different regions and countries are needed because there were not many studies on *T. leonina* in cats.

In terms of the efficacy and safety of the topical emodepside/praziquantel formulation (Profender® spot-on), the results of this study showed that the drug is safe and effective against gastrointestinal parasites of cats. Five days after applying the treatment, all the gastrointestinal parasites (n=159) yielded negative results in fecal examination, which means that the treatment had high efficacy. In a study conducted using the same treatment, 100% efficacy was recorded against mature and immature *A. tubaeforme* in domestic cats \[[@b24-kjp-57-3-243]\]. According to Reinemeyer et al. \[[@b25-kjp-57-3-243]\], this emodepside/praziquantel topical solution is effective against all stages of *T. cati*, yielding 100% efficacy against both mature and immature adults. Compared to oral adminstration of anthelmintics, topical application is more convenient, especially for cats \[[@b26-kjp-57-3-243]\].

In conclusion, the results in this study showed that gastrointestinal parasites in cats in Daegu, Republic of Korea, are prevalent and *T. cati* forming the largest portion of cases. The high prevalence of gastrointestinal parasites in cats suggests a possibility that cats are easily exposed not only to gastrointestinal parasites but also other pathogens, emphasizing the need for regular medical check-ups. In addition, treatment of gastrointestinal parasites in cats using emodepside/praziquantel formulation showed high safety and efficacy.
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###### 

Prevalence of gastrointestinal parasite infection in cats in Daegu, Republic of Korea, according to sex, age, and type of cat (companion/stray)

  Category            No. of tested   Positive (%) with parasitic infection   95% CI       *P*-value
  ------------------- --------------- --------------------------------------- ------------ -----------
  Sex                                                                                      
   Male               195             39.0                                    32.1--45.8   0.743
   Female             212             40.6                                    34.0--47.2   
                                                                                           
  Age                                                                                      
   Young (\<1 year)   218             36.2                                    29.9--42.6   0.115
   Adult (≥1 year)    189             43.9                                    36.8--51.0   
                                                                                           
  Type of cat                                                                              
   Companion          224             29.0                                    23.1--35.0   \<0.001
   Stray              183             39.8                                    45.8--60.2   
                                                                                           
  Total               407             39.8                                    35.1--44.6   

###### 

Prevalence of gastrointestinal parasite infection in cats in Daegu, Republic of Korea, for the four observed parasite species

  Parasite species         Number positive (%, 95% CI)                                                                                                                                           
  ------------------------ ----------------------------- ----------------------- ------- ----------------------- ----------------------- ------- ----------------------- ----------------------- -------
  *Toxocara cati*          48 (24.6, 18.6--30.7)         54 (25.5, 19.6--31.3)   0.842   48 (22.0, 16.5--27.5)   54 (28.6, 22.1--35.0)   0.128   43 (19.2, 14.0--24.4)   59 (32.2, 25.5--39.0)   0.003
                                                                                                                                                                                                 
  *Toxascaris leonina*     25 (12.8, 8.1--17.5)          26 (12.3, 7.9--16.7)    0.866   24 (11.0, 6.9--15.2)    27 (14.3, 9.3--19.3)    0.319   17 (7.6, 4.1--11.1)     34 (18.6, 12.9--24.2)   0.001
                                                                                                                                                                                                 
  *Taenia taeniaeformis*   1 (0.5, 0--1.5)               5 (2.4, 0.3--4.4)       0.218   4 (1.8, 0.1--3.6)       2 (1.1, 0--2.5)         0.690   4 (1.8, 0.1--3.5)       2 (1.1, 0--2.6)         0.695
                                                                                                                                                                                                 
  *Cystoisospora felis*    2 (1.0, 0--2.4)               1 (0.5, 0--1.4)         0.609   3 (1.4, 0--2.9)         0                       0.252   1 (0.4, 0--1.3)         2 (1.1, 0--2.6)         0.590

###### 

Prevalence and intensity of infection of the cats with endoparasites in Daegu, Republic of Korea

  Species                  No. (%) of cats infected   Severity (%) of infection[\*](#tfn1-kjp-57-3-243){ref-type="table-fn"}               
  ------------------------ -------------------------- ------------------------------------------------------------------------ ----------- ---
  *Toxocara cati*          102 (63.0)                 92                                                                       10          0
  *Toxascaris leonina*     51 (31.5)                  41                                                                       10          0
  *Taenia taeniaeformis*   6 (3.7)                    5                                                                        1           0
  *Cystoisospora felis*    3 (1.9)                    2                                                                        1           0
                                                                                                                                           
  Total                    162                        140 (86.4)                                                               22 (13.6)   0

Mild: EPG\<1,000; Moderate: 1,000≤EPG\<10,000; Severe: EPG≥10,000.
